WHO ICTRP trial
CONSERVE II – Preventing Iatrogenic Anaemia in Malignant Haematology Inpatients…
ACTRN12625000381482 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12625000381482 |
|---|---|
| Public title | CONSERVE II – Preventing Iatrogenic Anaemia in Malignant Haematology Inpatients: a pilot randomised controlled trial |
| Scientific title | CONSERVE II – Efficacy of Preventing Iatrogenic Anaemia through Blood Conservation Strategies in Malignant Haematology Inpatients Commencing Chemotherapy Protocols: a pilot feasibility randomised controlled trial |
| Primary sponsor | Queensland University of Technology |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Anaemia ; Anaemia ;Blood - Anaemia;Blood - Haematological diseases;Cancer - Hodgkin's;Cancer - Leukaemia - Acute leukaemia;Cancer - Leukaemia - Chronic leukaemia;Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma;Cancer… |
| Interventions | Intervention group: blood sampling frequency will occur as per standard of care. The following interventions will be implemented when blood is required for sampling: - CVAD discard volume will be reduced from 10mL as per standard of care… |
| Registration date | Apr 29, 2025 |
| Target size | 100 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: